stars 1 stars 2 stars 3

Sikalias Pharmaceutical Laboratories is a Greek development and manufacturing partner for health and wellness products. We support pharmaceutical, nutraceutical, medical device, FSMP and cosmetic companies that need a reliable path from client brief and development to industrial scale-up and commercial manufacturing. Our two-site operating model in Peristeri combines development, analytical work, pilot support, QC and GMP operations with broader industrial manufacturing capability. Depending on project requirements, we support liquid, semi-solid and selected solid dosage forms, together with automated lines, low-humidity capability for selected projects and documented manufacturing workflows. Our regulatory-compliance work is integrated within QA and focuses on technical documentation and factory-side compliance support. For registration projects, we work in coordination with the client’s appointed regulatory office and/or MAH structure. If you are looking for a dependable partner for development, scale-up or outsourced manufacturing, let’s connect.

Sikalias Pharmaceutical Laboratories Questions

The Sikalias Pharmaceutical Laboratories annual revenue was $1 million in 2026.

Stasinos Sikalias is the CEO and Managing Director of Sikalias Pharmaceutical Laboratories.

7 people are employed at Sikalias Pharmaceutical Laboratories.

Sikalias Pharmaceutical Laboratories is based in Peristeri, Attica.

The NAICS codes for Sikalias Pharmaceutical Laboratories are [325, 32, 3254, 32541].

The SIC codes for Sikalias Pharmaceutical Laboratories are [28, 283].

G2 Leader Summer 2026 G2 Best Est ROI Mid-Market Summer 2026 G2 Easiest Admin Mid-Market Summer 2026 G2 Most Implementable Summer 2026 G2 Best Results Mid-Market Summer 2026 G2 Lead Capture Mid-Market Summer 2026 Inc Fastest Growing Private Companies 2026 Inc Best Workplace 2026
g2crowd
G2Crowd Trusted
chromestore
300K+ Plugin Users